Researchers have turned artificial intelligence into a powerful new lens for understanding why cancer survival rates differ ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

For the first time, researchers have used machine learning—a type of artificial intelligence (AI)—to identify the most ...

AI has revealed why cancer survival differs so dramatically around the world, highlighting the specific health system factors that matter most in each country.

A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the Sbarro Institute in Philadelphia, the National Cancer Institute – Pascale ...

The integration of artificial intelligence (AI) with imaging has emerged as a transformative force in the field of oral oncology. Oral cancer remains a ...

Deep learning model analyzes mammograms to predict breast cancer risk up to five years in advance, now being tested at ...

Microsoft is testing a new product that coordinates AI agents for multi-disciplinary care teams. In the new era of agentic AI, Microsoft is creating technology to help AI agents work together and ...

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine. Diagnosing kidney cancer ...